2019 Pathology Core Facility (PCF) Biobank Grant Awardees
The Lurie Cancer Center is pleased to announce the recipients of four new Biobank Awards, selected to accelerate the usage of cancer biospecimens for translational research and novel clinical approaches. The awardees and the focal points of their research projects are:
"Immune Control of Triple-Negative Breast Cancers by WEE1 Inhibition” Bin Zhang, MD, PhD |
|
"Investigating Intratumoral Heterogeneity Marc Mendillo, PhD |
|
"Integrin a2 Drives Triple Negative Huiping Liu, MD, PhD |
|
"Cathepsin Activity as a Biomarker Elias Gounaris, PhD
|